efalizumab - subcutaneous injection, Raptiva
GENERIC NAME: EFALIZUMAB - SUBCUTANEOUS INJECTION (EF-a-LIZ-ue-mab)
BRAND NAME(S): Raptiva
WARNING: Efalizumab decreases immune system function (immunosuppression), which can result in very serious (possibly fatal) infections (e.g., tuberculosis, meningitis, PML), or a worsening of an existing infection. Seek immediate medical attention if you develop signs of serious infection such as persistent fever/cough, difficulty breathing, confusion, loss of balance, sudden vision/speech problems.
Back to Medications Index
Get the latest health and medical information delivered direct to your inbox FREE!